IK-595

N/A

Report date: 2025/09/20 20:00:09
NME

Base Information

Drug NameIK-595
Drug Alias NameIK-595
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMEK-CRAF protein complex inhibitors
TargetsMEK-CRAF protein complex
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungThyroid Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIkena Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIkena Oncology Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungThyroid Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A